Shares of Envista Holdings Corporation (NYSE:NVST – Get Free Report) have been assigned a consensus recommendation of “Hold” from the fifteen brokerages that are covering the company, MarketBeat reports. Nine analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $28.6667.
NVST has been the topic of several research reports. Citigroup initiated coverage on shares of Envista in a report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price target on the stock. Morgan Stanley boosted their target price on shares of Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, April 24th. Weiss Ratings downgraded shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. JPMorgan Chase & Co. raised their price objective on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, Evercore restated an “outperform” rating and set a $33.00 price objective on shares of Envista in a research report on Thursday, May 7th.
Check Out Our Latest Report on Envista
Institutional Trading of Envista
Envista Trading Down 1.3%
Shares of NVST opened at $27.16 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. Envista has a 52-week low of $18.77 and a 52-week high of $30.42. The firm has a market cap of $4.42 billion, a price-to-earnings ratio of 66.25, a PEG ratio of 1.56 and a beta of 0.86. The business’s fifty day moving average is $24.87 and its 200-day moving average is $25.37.
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The business had revenue of $705.50 million during the quarter, compared to the consensus estimate of $680.03 million. During the same period in the prior year, the company earned $0.24 EPS. Envista’s revenue for the quarter was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts anticipate that Envista will post 1.42 EPS for the current fiscal year.
Envista Company Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Further Reading
- Five stocks we like better than Envista
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
